TCL Archive Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials March 28, 1986
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years March 6, 1998
